NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

IPO Market Update: Multiple Issues Open Amid Cautious Sentiment

The primary market is experiencing a busy week with several Initial Public Offerings (IPOs) opening simultaneously. The Amir Chand Jagdish Kumar (Exports) Ltd IPO, a ₹440 crore fresh issue, opened on March 24 and will close on March 27. The issue has seen moderate investor interest despite muted grey market signals.

Other notable IPOs include Powerica Ltd and Sai Parenteral's Ltd. The Sai Parenteral's IPO is a pharmaceutical offering with a price band of ₹372– ₹392 per share. The Powerica IPO has also opened for subscription, but has limited grey market traction. In contrast, the Central Mine Planning and Design Institute Ltd (CMPDI) IPO, which opened on March 20 and closes on March 24, has seen steady interest due to its strong parentage and sector positioning.

Grey Market Sentiment

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Market sentiment in the grey market remains largely subdued. The Amir Chand Jagdish Kumar IPO is commanding a modest ₹6 Grey Market Premium (GMP), indicating a mild listing premium of about 3%. In contrast, the Powerica IPO has seen a sharp decline in GMP to near zero (₹6– ₹7 range earlier), reflecting soft investor appetite. The Sai Parenteral's IPO is trading at a flat GMP of ₹0, signaling muted expectations. The CMPDI IPO is quoting at just around Re 1 premium (~0.6%), indicating limited listing gains.

Investor Takeaway

Investors should be cautious and monitor the market sentiment before investing in these IPOs.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.